Lung Neoplasms: all 7,334 studies

Page 51 of 74. Open to participants first (1,555), then studies with results posted, then the rest; newest registration first within each.

• M6620 and Irinotecan Hydrochloride in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryActive, not recruitingNCT02595931Phase 1
• Phase II, Single-arm Study of AZD1775 Monotherapy in Relapsed Small Cell Lung Cancer PatientsCompletedNCT02593019Phase 2
• A Clinical Trial of Fruquintinib in Patients With Advanced Non-small Cell Lung CancerCompletedNCT02590965Phase 2
• Study of Stereotactic Ablative Radiotherapy (SABR) in Elderly Stage I NSCLCStatus unknownNCT02584699Phase 2
• A Study of AZD2014 in Combination With Selumetinib in Patients With Advanced CancersStatus unknownNCT02583542Phase 1/2
• ONO-4538 Study in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT02582125Phase 2
• Pembrolizumab in Untreated Extensive SCLCCompletedNCT02580994Phase 2
• Phase 1/2 Study of the Safety and Efficacy of Rociletinib in Combination With Trametinib in Patients With mEGFR-positive Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT02580708Phase 1/2
• Systemic Chemotherapy Combined With Recombinant Human Adenovirus Type 5 and Endostatin Injections for Treatment Malignant Hydrothorax in NSCLC PatientsStatus unknownNCT02579564Phase 3
• Radio-Immuno-Modulation in Lung CancerSuspendedNCT02579005Phase 1
• Multi-Indication, Retrospective Oncological Study to Validate the Accuracy in Predicting TTP by PrediCare in Patients Under SOCStatus unknownNCT02577627
• Study of Epigallocatechin-3-gallate (EGCG) for Esophagus Protection in Patients With Lung Cancer Receiving Radial RadiotherapyStatus unknownNCT02577393Phase 2
• Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung CancerCompletedNCT02577341Phase 2
• Feasibility of a Creative Writing Intervention in an Advanced Cancer Population: A Single Arm, Consecutive Cohort StudyCompletedNCT02575898Not applicable
• GR-MD-02 Plus Pembrolizumab in Melanoma, Non-small Cell Lung Cancer, and Squamous Cell Head and Neck Cancer PatientsCompletedNCT02575404Phase 1
• Study of Split-course Chemoradiotherapy For Locally Advanced None-small Cell Lung CancerCompletedNCT02573506Phase 2
• ENB Robotic ICG Guided Surgery: A Novel Technique for Targeting Small Lung TumorsWithdrawnNCT02570958Phase 1
• Stereotactic Radiosurgery and Systemic Dose Chemotherapy for Locally Advanced Lung CancerStatus unknownNCT02568033Early Phase 1
• Talazoparib in Treating Patients With Advanced or Metastatic Solid Tumors That Cannot Be Removed by Surgery and Liver or Kidney DysfunctionWithdrawnNCT02567396Phase 1
• Genomic Sequencing in Determining Treatment in Patients With Metastatic Cancer or Cancer That Cannot Be Removed by SurgeryTerminatedNCT02566421Not applicable
• Study of Pembrolizumab Maintenance Following First-Line Platinum Based Chemotherapy in Patients With Metastatic Squamous - Non-Small Cell Lung Cancer (sNSCLC)TerminatedNCT02564380Phase 2
• SBRT (Stereotactic Body Radiation Therapy) vs. Surgery in High Risk Patients With Early Stage Lung CancerCompletedNCT02562027Not applicable
• Gut Microbiota And RadiotherapyCompletedNCT02559349
• Lung Screen Uptake TrialCompletedNCT02558101Not applicable
• IMRT Combined With Erlotinib for EGFR Wild Type Non-small Cell Lung Cancer With 4-10 Brain MetastasesTerminatedNCT02556593Phase 2
• Strategy of Surgical Resection With Adjuvant Therapy for IIIA NSCLC and N2 Disease Only in Subaortic or Paraaortic LevelStatus unknownNCT02555592
• Metronomic Chemotherapy Based on Adaptative Bio-mathematical Model of Oral Vinorelbine in Patients With NSCLC or MPMCompletedNCT02555007Phase 1
• Genomic Landscape of CeritinibTerminatedNCT02554591
• Identification of Prognostic Biomarkers for Progression of Invasive Squamous Cell CarcinomaTerminatedNCT02549638
• Nimotuzumab in Combination With Radiochemotherapy for Patients With Stage IIIA/IIIB Non-small Cell Lung CancerStatus unknownNCT02549261Not applicable
• Rociletinib (CO-1686) USA Expanded Access ProgramNo longer availableNCT02547675
• Abscopal Effect for Metastatic Non-small Cell Lung Cancer.WithdrawnNCT02542930Phase 2
• Are Doctors Familiar With the Test Characteristics of Lung Cancer Screening?CompletedNCT02542332Not applicable
• Abscopal Effect for Metastatic Small Cell Lung CancerWithdrawnNCT02542137Phase 2
• Study of Apatinib in RET Fusion Positive Advanced Non-small Cell Lung CancerStatus unknownNCT02540824Phase 2
• Deep Inspiration Breath Hold as Primary Strategy for Locally Advanced Lung Cancer RadiotherapyCompletedNCT02540499Not applicable
• Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer : Interest of an Addiction TreatmentCompletedNCT02540174Not applicable
• EUS-B-FNA vs EUS-FNA for Left Adrenal Gland Analysis in Lung Cancer PatientsStatus unknownNCT02538380Not applicable
• Talazoparib in Combination With Gemcitabine and Cisplatin in Patients With Advanced Solid TumorsWithdrawnNCT02537561Phase 1
• Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung CancerWithdrawnNCT02536495Phase 1/2
• Efficacy and Safety of Pyrotinib in Patients With HER2 Mutation Advanced Non-Small Cell Lung CancerStatus unknownNCT02535507Phase 2
• The Pittsburgh Vitamin D Study: Vitamin D Supplementation in Vitamin D-deficient Subjects at Risk of Lung CancerTerminatedNCT02532062Not applicable
• Nintedanib (Vargatef®) Plus Docetaxel in Second Line of Treatment in Patients With Lung CancerCompletedNCT02531737Phase 2
• Intervention to Improve Supportive Care for Family Caregivers of Patients With Lung CancerCompletedNCT02531464Not applicable
• MPDL3280A With Chemoradiation for Lung CancerActive, not recruitingNCT02525757Phase 2
• HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Lung CancerCompletedNCT02523404Phase 1/2
• An Open-label Phase Ib/II Study of BAY 1000394 (Roniciclib) in Combination With Docetaxel in Second- or Third-line Treatment of Patients With Advanced Non-small Cell Lung Cancer (NSCLC)WithdrawnNCT02522910Phase 1/2
• Low-dose Computed Tomography Screening for Lung Cancer in Relatives With Family History of Lung CancerCompletedNCT02519972Not applicable
• Pemetrexed Combined With Synchronous Gefitinib as Adjuvent Therapy in Patient With EGFR Mutant Lung AdenocarcinomaStatus unknownNCT02518802Phase 3
• Tumor-specific T Cells in Lung CancerActive, not recruitingNCT02515760Not applicable
• The Efficacy and Safety of Apatinib in Heavily Pretreated Advanced Non-squamous Non-small Cell Lung CancerStatus unknownNCT02515435Phase 2
• Lung Cancer Radiotherapy Using Realtime Dynamic Multileaf Collimator (MLC) Adaptation And Radiofrequency TrackingActive, not recruitingNCT02514512Not applicable
• Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical ResearchStatus unknownNCT02513355Phase 4
• AZD1775 Combined With Olaparib in Patients With Refractory Solid TumorsCompletedNCT02511795Phase 1
• Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung CancerStatus unknownNCT02507518Phase 2
• Dynamic PET CT as a Tool for Treatment Efficacy Monitoring in Lung CancerStatus unknownNCT02505685
• Efficacy of Nebulized Pulmicort Respules in Primary Lung Cancer Patients With COPDStatus unknownNCT02504801Phase 4
• AZD9291, an Irreversible EGFR-TKI, in Relapsed EGFR-mutated Non-small Cell Lung Cancer Patients Previously Treated With an EGFR-TKI, Coupled to Extensive Translational StudiesStatus unknownNCT02504346Phase 2
• Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lung CancerCompletedNCT02503358Phase 1
• A Study to Optimize Care for Lung Cancer Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)CompletedNCT02502695
• Medicoeconomic Evaluation of Two Surgical Techniques for Lobectomy in the Lung CancerTerminatedNCT02502318Not applicable
• ALK Rearrangements in Lung Adenocarcinoma: Epidemiology in Latin America (CLICaP)Status unknownNCT02502240
• The Prevalence of Lung Cancer in Patients With Interstitial Lung DiseaseCompletedNCT02501668
• A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR MutationsTerminatedNCT02500927Phase 2
• SC-002 in Small Cell Lung Cancer and Large Cell Neuroendocrine CarcinomaTerminatedNCT02500914Phase 1
• Circulating Tumor Cells in Lung Cancer ScreeningCompletedNCT02500693Not applicable
• Efficacy and Safety of Adjuvant Pemetrexed Plus Cisplatin for Adenocarcinoma of LungCompletedNCT02498860Phase 2
• Optimizing (Breathing) Techniques for Radiotherapy of Esophageal and Lung CarcinomasCompletedNCT02497664Not applicable
• Feasibility of Magnetic Resonance Spectroscopy in Lung CancerStatus unknownNCT02497586Not applicable
• Recombinant Human Endostatin Combined With NP in Neoadjuvant Chemotherapy of Stage ⅢA NSCLCCompletedNCT02497118Phase 4
• Osimertinib and Necitumumab in Treating Patients With EGFR-Mutant Stage IV or Recurrent Non-small Cell Lung Cancer Who Have Progressed on a Previous EGFR Tyrosine Kinase InhibitorActive, not recruitingNCT02496663Phase 1
• Cone-beam CT Guided Microcoil Localization of Pulmonary Nodules During Video Assisted Thoracic Surgery(VATS)CompletedNCT02496624Not applicable
• Phase 2 Study of MPDL3280A Combined With CDX-1401 in NY-ESO 1 (+) IIIB, IV or Recurrent Non-Small Cell Lung CancerWithdrawnNCT02495636Phase 2
• Physical Functioning Throughout Lung Cancer TreatmentCompletedNCT02493114
• Pembrolizumab After SBRT Versus Pembrolizumab Alone in Advanced NSCLCCompletedNCT02492568Phase 2
• Afatinib Genomic LandscapeTerminatedNCT02491775
• Comparative Study of the Hypoxia Measured in FAZA and F-miso PET/CT Scan in Patients With Non-small Cell Lung CancerCompletedNCT02490696Phase 2
• E- Predict: EBUS ELASTOGRAPHY STRAIN in Lung CancerCompletedNCT02488928
• Determination of Peripheral Immune Cell Activity During Treatment With Either Surgery or Radiotherapy in Patients With Early Stage NSCLCCompletedNCT02488850Not applicable
• Maintaining ERBB Blockade in EGFR-mutated Lung CancerTerminatedNCT02488694Phase 2
• Phase II Trial of HM61713 for the Treatment of ≥2nd Line T790M Mutation Positive Adenocarcinoma of the LungTerminatedNCT02485652Phase 2
• Has Inflammation a Significant Implication in Lung Cancer Evolution?Status unknownNCT02484872
• RejuvenAir Lobectomy for Safety and HistologyCompletedNCT02483052Phase 1/2
• 68Ga-AlfatideII for the Differential Diagnosis of of Lung Cancer and Lung Tuberculosis by PET/CTCompletedNCT02481726Phase 1/2
• Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLCStatus unknownNCT02481661Phase 3
• Zoledronic Acid Combined Radiotherapy for Bone Metastasis of Non-small Cell Lung CancerStatus unknownNCT02480634Phase 4
• Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT MethylationTerminatedNCT02477813Phase 2
• Safety of Low Dose IV Contrast CT Scanning in Chronic Kidney DiseaseCompletedNCT02476526Phase 4
• Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic RegimenNo longer availableNCT02475382
• Dietary Flaxseed in NSCLCTerminatedNCT02475330Phase 2
• Evaluation of Safety and Efficacy of DCVAC/LuCa (Immunotherapy of Lung Cancer) in Patients With Metastatic Lung CancerCompletedNCT02470468Phase 1/2
• Neoadjuvant Afatinib in Early Stage Non Small Cell Lung Cancer.SuspendedNCT02470065Phase 2
• The Effect and Mechanism of Electroacupuncture on Acute Chemotherapy-induced Nausea and VomitingStatus unknownNCT02469493Not applicable
• A Safety and Efficacy Study of INC280 Alone, and in Combination With Erlotinib, Compared to Chemotherapy, in Advanced/Metastatic Non-small Cell Lung Cancer Patients With EGFR Mutation and cMET AmplificationTerminatedNCT02468661Phase 1
• Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)Active, not recruitingNCT02465060Phase 2
• A Pilot Study of MPDL3280A and HIGRT in Metastatic NSCLCCompletedNCT02463994Early Phase 1
• Multiple-portal VATS Versus Uniportal VATS Lobectomy for Non-small Cell Lung CancerStatus unknownNCT02462356Not applicable
• Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung CancerTerminatedNCT02460367Phase 1
• Prospective Study to Determine Impact of Early Palliative Care Consult on Quality of Life (QOL), Cancer Related Symptoms In Advanced Lung Cancer Patients: Thoracic Pilot ProjectCompletedNCT02459002
• Disease Characteristics, Treatment Patterns and Clinical Outcomes in Patients With Newly Diagnosed Unresectable Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) in ChinaCompletedNCT02458651

← Lung Neoplasms overview